217 related articles for article (PubMed ID: 30478162)
1. Comparative Genomics of Serial
Barber AE; Weber M; Kaerger K; Linde J; Gölz H; Duerschmied D; Markert A; Guthke R; Walther G; Kurzai O
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478162
[TBL] [Abstract][Full Text] [Related]
2. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
3. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
[TBL] [Abstract][Full Text] [Related]
4. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.
Zimbeck AJ; Iqbal N; Ahlquist AM; Farley MM; Harrison LH; Chiller T; Lockhart SR
Antimicrob Agents Chemother; 2010 Dec; 54(12):5042-7. PubMed ID: 20837754
[TBL] [Abstract][Full Text] [Related]
5. Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment.
Fraser M; Borman AM; Thorn R; Lawrance LM
Med Mycol; 2020 Feb; 58(2):219-226. PubMed ID: 31111912
[TBL] [Abstract][Full Text] [Related]
6. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.
Bordallo-Cardona MÁ; Escribano P; de la Pedrosa EG; Marcos-Zambrano LJ; Cantón R; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872063
[TBL] [Abstract][Full Text] [Related]
8. Novel
Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
[TBL] [Abstract][Full Text] [Related]
9. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
[No Abstract] [Full Text] [Related]
10. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia.
Imbert S; Castain L; Pons A; Jacob S; Meyer I; Palous M; Vezinet C; Langeron O; Hennequin C; Monsel A; Fekkar A
Clin Microbiol Infect; 2016 Oct; 22(10):891.e5-891.e8. PubMed ID: 27484020
[TBL] [Abstract][Full Text] [Related]
12. Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.
Zhao Y; Nagasaki Y; Kordalewska M; Press EG; Shields RK; Nguyen MH; Clancy CJ; Perlin DS
Antimicrob Agents Chemother; 2016 Nov; 60(11):6573-6577. PubMed ID: 27550360
[TBL] [Abstract][Full Text] [Related]
13.
Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
[TBL] [Abstract][Full Text] [Related]
14. Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells.
Garcia-Rubio R; Jimenez-Ortigosa C; DeGregorio L; Quinteros C; Shor E; Perlin DS
mBio; 2021 Aug; 12(4):e0195921. PubMed ID: 34372698
[TBL] [Abstract][Full Text] [Related]
15. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.
Klotz U; Schmidt D; Willinger B; Steinmann E; Buer J; Rath PM; Steinmann J
Mycoses; 2016 May; 59(5):312-8. PubMed ID: 26806376
[TBL] [Abstract][Full Text] [Related]
16. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
[No Abstract] [Full Text] [Related]
17. Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.
Lewis JS; Wiederhold NP; Wickes BL; Patterson TF; Jorgensen JH
Antimicrob Agents Chemother; 2013 Sep; 57(9):4559-61. PubMed ID: 23817368
[TBL] [Abstract][Full Text] [Related]
18. Antifungal resistance does not necessarily affect Candida glabrata fitness.
Borghi E; Andreoni S; Cirasola D; Ricucci V; Sciota R; Morace G
J Chemother; 2014 Feb; 26(1):32-6. PubMed ID: 24091025
[TBL] [Abstract][Full Text] [Related]
19. Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata.
Hu C; Fong G; Wurster S; Kontoyiannis DP; Beyda ND
Microbiol Spectr; 2022 Feb; 10(1):e0183721. PubMed ID: 35107318
[TBL] [Abstract][Full Text] [Related]
20. Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong
Schell WA; Jones AM; Garvey EP; Hoekstra WJ; Schotzinger RJ; Alexander BD
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
